Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn?t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy. This report contains market size and forecasts of Oncolytic Virus Therapy in global, including the following market information:
Global Oncolytic Virus Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncolytic Virus Therapy market was valued at US$ 6 million in 2022 and is projected to reach US$ 28 million by 2029, at a CAGR of 23.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
We surveyed the Oncolytic Virus Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncolytic Virus Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncolytic Virus Therapy Market Segment Percentages, by Type, 2022 (%)
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Global Oncolytic Virus Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncolytic Virus Therapy Market Segment Percentages, by Application, 2022 (%)
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Global Oncolytic Virus Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncolytic Virus Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncolytic Virus Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncolytic Virus Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncolytic Virus Therapy, market overview.
Chapter 2: Global Oncolytic Virus Therapy market size in revenue.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncolytic Virus Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Therapy Overall Market Size
2.1 Global Oncolytic Virus Therapy Market Size: 2022 VS 2029
2.2 Global Oncolytic Virus Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Therapy Players in Global Market
3.2 Top Global Oncolytic Virus Therapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncolytic Virus Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncolytic Virus Therapy Market Size Markets, 2022 & 2029
4.1.2 HSV-based Oncolytic Viruses
4.1.3 Adenoviruses-based Oncolytic Viruses
4.1.4 Vaccinia Virus-based Oncolytic Viruses
4.1.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
4.1.6 Newcastle Disease Virus-based Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Therapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Therapy Revenue, 2018-2023
4.2.2 By Type - Global Oncolytic Virus Therapy Revenue, 2024-2029
4.2.3 By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Therapy Market Size, 2022 & 2029
5.1.2 Melanoma
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Ovarian Cancer
5.1.6 Others
5.2 By Application - Global Oncolytic Virus Therapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Therapy Revenue, 2018-2023
5.2.2 By Application - Global Oncolytic Virus Therapy Revenue, 2024-2029
5.2.3 By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Therapy Market Size, 2022 & 2029
6.2 By Region - Global Oncolytic Virus Therapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Therapy Revenue, 2018-2023
6.2.2 By Region - Global Oncolytic Virus Therapy Revenue, 2024-2029
6.2.3 By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Therapy Revenue, 2018-2029
6.3.2 US Oncolytic Virus Therapy Market Size, 2018-2029
6.3.3 Canada Oncolytic Virus Therapy Market Size, 2018-2029
6.3.4 Mexico Oncolytic Virus Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Therapy Revenue, 2018-2029
6.4.2 Germany Oncolytic Virus Therapy Market Size, 2018-2029
6.4.3 France Oncolytic Virus Therapy Market Size, 2018-2029
6.4.4 U.K. Oncolytic Virus Therapy Market Size, 2018-2029
6.4.5 Italy Oncolytic Virus Therapy Market Size, 2018-2029
6.4.6 Russia Oncolytic Virus Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Oncolytic Virus Therapy Market Size, 2018-2029
6.4.8 Benelux Oncolytic Virus Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Therapy Revenue, 2018-2029
6.5.2 China Oncolytic Virus Therapy Market Size, 2018-2029
6.5.3 Japan Oncolytic Virus Therapy Market Size, 2018-2029
6.5.4 South Korea Oncolytic Virus Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Oncolytic Virus Therapy Market Size, 2018-2029
6.5.6 India Oncolytic Virus Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Therapy Revenue, 2018-2029
6.6.2 Brazil Oncolytic Virus Therapy Market Size, 2018-2029
6.6.3 Argentina Oncolytic Virus Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, 2018-2029
6.7.2 Turkey Oncolytic Virus Therapy Market Size, 2018-2029
6.7.3 Israel Oncolytic Virus Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Oncolytic Virus Therapy Market Size, 2018-2029
6.7.5 UAE Oncolytic Virus Therapy Market Size, 2018-2029
7 Oncolytic Virus Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Therapy Major Product Offerings
7.1.4 Amgen Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Company Summary
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Major Product Offerings
7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.2.5 Oncolytics Biotech Key News & Latest Developments
7.3 Viralytics
7.3.1 Viralytics Company Summary
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Therapy Major Product Offerings
7.3.4 Viralytics Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.3.5 Viralytics Key News & Latest Developments
7.4 Transgene SA
7.4.1 Transgene SA Company Summary
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Therapy Major Product Offerings
7.4.4 Transgene SA Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.4.5 Transgene SA Key News & Latest Developments
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Company Summary
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Major Product Offerings
7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.5.5 Oncolys BioPharma Key News & Latest Developments
7.6 Targovax
7.6.1 Targovax Company Summary
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Therapy Major Product Offerings
7.6.4 Targovax Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.6.5 Targovax Key News & Latest Developments
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Company Summary
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.7.5 PsiOxus Therapeutics Key News & Latest Developments
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Company Summary
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.8.5 SillaJen Biotherapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Lokon Pharma
7.10.1 Lokon Pharma Company Summary
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Therapy Major Product Offerings
7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.10.5 Lokon Pharma Key News & Latest Developments
7.11 Genelux Corporation
7.11.1 Genelux Corporation Company Summary
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Therapy Major Product Offerings
7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.11.5 Genelux Corporation Key News & Latest Developments
7.12 Vyriad
7.12.1 Vyriad Company Summary
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Therapy Major Product Offerings
7.12.4 Vyriad Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.12.5 Vyriad Key News & Latest Developments
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Company Summary
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.13.5 TILT Biotherapeutics Key News & Latest Developments
7.14 Cold Genesys
7.14.1 Cold Genesys Company Summary
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Therapy Major Product Offerings
7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue in Global Market (2018-2023)
7.14.5 Cold Genesys Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncolytic Virus Therapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Therapy Market Drivers in Global Market
Table 3. Oncolytic Virus Therapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Therapy in Global Market
Table 5. Top Oncolytic Virus Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncolytic Virus Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncolytic Virus Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncolytic Virus Therapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncolytic Virus Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncolytic Virus Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncolytic Virus Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncolytic Virus Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncolytic Virus Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Oncolytic Virus Therapy Product Offerings
Table 32. Amgen Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Oncolytics Biotech Company Summary
Table 35. Oncolytics Biotech Oncolytic Virus Therapy Product Offerings
Table 36. Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Oncolytics Biotech Key News & Latest Developments
Table 38. Viralytics Company Summary
Table 39. Viralytics Oncolytic Virus Therapy Product Offerings
Table 40. Viralytics Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Viralytics Key News & Latest Developments
Table 42. Transgene SA Company Summary
Table 43. Transgene SA Oncolytic Virus Therapy Product Offerings
Table 44. Transgene SA Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Transgene SA Key News & Latest Developments
Table 46. Oncolys BioPharma Company Summary
Table 47. Oncolys BioPharma Oncolytic Virus Therapy Product Offerings
Table 48. Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Oncolys BioPharma Key News & Latest Developments
Table 50. Targovax Company Summary
Table 51. Targovax Oncolytic Virus Therapy Product Offerings
Table 52. Targovax Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Targovax Key News & Latest Developments
Table 54. PsiOxus Therapeutics Company Summary
Table 55. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offerings
Table 56. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. PsiOxus Therapeutics Key News & Latest Developments
Table 58. SillaJen Biotherapeutics Company Summary
Table 59. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 60. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. SillaJen Biotherapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Company Summary
Table 63. Sorrento Therapeutics Oncolytic Virus Therapy Product Offerings
Table 64. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Lokon Pharma Company Summary
Table 67. Lokon Pharma Oncolytic Virus Therapy Product Offerings
Table 68. Lokon Pharma Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Lokon Pharma Key News & Latest Developments
Table 70. Genelux Corporation Company Summary
Table 71. Genelux Corporation Oncolytic Virus Therapy Product Offerings
Table 72. Genelux Corporation Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Genelux Corporation Key News & Latest Developments
Table 74. Vyriad Company Summary
Table 75. Vyriad Oncolytic Virus Therapy Product Offerings
Table 76. Vyriad Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Vyriad Key News & Latest Developments
Table 78. TILT Biotherapeutics Company Summary
Table 79. TILT Biotherapeutics Oncolytic Virus Therapy Product Offerings
Table 80. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. TILT Biotherapeutics Key News & Latest Developments
Table 82. Cold Genesys Company Summary
Table 83. Cold Genesys Oncolytic Virus Therapy Product Offerings
Table 84. Cold Genesys Oncolytic Virus Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Cold Genesys Key News & Latest Developments
List of Figures
Figure 1. Oncolytic Virus Therapy Segment by Type in 2022
Figure 2. Oncolytic Virus Therapy Segment by Application in 2022
Figure 3. Global Oncolytic Virus Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncolytic Virus Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2022
Figure 8. By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oncolytic Virus Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 16. US Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 28. China Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oncolytic Virus Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oncolytic Virus Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Oncolytics Biotech Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Viralytics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Transgene SA Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Oncolys BioPharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Targovax Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sorrento Therapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lokon Pharma Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genelux Corporation Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Vyriad Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. TILT Biotherapeutics Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Cold Genesys Oncolytic Virus Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
